Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CZL80

😃Good
Catalog No. T86155Cas No. 313482-91-6
Alias CZL-80, CZL 80

CZL80 is a brain-penetrant caspase-1 inhibitor with an IC50 of 0.01 μM that is used to study febrile seizures and subsequent epileptogenic susceptibility. CZL80 reduces neuronal excitability, decreases the incidence of febrile seizure generation at 7.5 mg/kg intravenously, and mitigates long-term neurological dysfunction following photothrombosis, establishing CZL80 as a valuable tool for neuroinflammation, seizure biology, and stroke-induced pathology.

CZL80

CZL80

😃Good
Purity: 99.48%
Catalog No. T86155Alias CZL-80, CZL 80Cas No. 313482-91-6
CZL80 is a brain-penetrant caspase-1 inhibitor with an IC50 of 0.01 μM that is used to study febrile seizures and subsequent epileptogenic susceptibility. CZL80 reduces neuronal excitability, decreases the incidence of febrile seizure generation at 7.5 mg/kg intravenously, and mitigates long-term neurological dysfunction following photothrombosis, establishing CZL80 as a valuable tool for neuroinflammation, seizure biology, and stroke-induced pathology.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$35-In Stock
5 mg$56-In Stock
10 mg$91-In Stock
25 mg$183-In Stock
50 mg$297-In Stock
100 mg$475-In Stock
1 mL x 10 mM (in DMSO)$62-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.48%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
CZL80 is a brain-penetrant caspase-1 inhibitor with an IC50 of 0.01 μM that is used to study febrile seizures and subsequent epileptogenic susceptibility. CZL80 reduces neuronal excitability, decreases the incidence of febrile seizure generation at 7.5 mg/kg intravenously, and mitigates long-term neurological dysfunction following photothrombosis, establishing CZL80 as a valuable tool for neuroinflammation, seizure biology, and stroke-induced pathology.
Targets&IC50
Caspase-1:0.01 μM
In vivo
CZL80 (10, 30 mg/kg/day, intraperitoneal injection, for 7 days) ameliorated motor dysfunction in C57BL/6 mice and Caspase-1⁻/⁻ mice after photothrombotic stroke [2].
CZL80 (0.0075, 0.075, 0.75, and 7.5 mg/kg, intravenous injection, administered every other day) reduced epileptic seizure incidence in a dose-dependent manner, prolonged epileptic seizure latency, and increased the induction threshold of high-grade fever febrile convulsions in Casp1⁻/⁻ mice [1].
SynonymsCZL-80, CZL 80
Chemical Properties
Molecular Weight366.39
FormulaC19H14N2O4S
Cas No.313482-91-6
SmilesO=C(O)C=1C=CC=C(C1)NC(=O)C=2C=CC=C(C2)NC(=O)C=3SC=CC3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: ≥ 160 mg/mL, Sonication is recommended.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy CZL80 | purchase CZL80 | CZL80 cost | order CZL80 | CZL80 chemical structure | CZL80 in vivo | CZL80 formula | CZL80 molecular weight